The insulin-like growth factor-I receptor as an oncogene - PubMed (original) (raw)
Review
The insulin-like growth factor-I receptor as an oncogene
Haim Werner et al. Arch Physiol Biochem. 2009 May.
Abstract
The insulin-like growth factor-I receptor (IGF-IR) mediates the biological actions of both IGF-I and IGF-II. The IGF-IR is expressed in most transformed cells, where it displays potent antiapoptotic, cell-survival, and transforming activities. IGF-IR expression is a fundamental prerequisite for the acquisition of a malignant phenotype, as suggested by the finding that IGF-IR-null cells (derived from IGF-IR knock-out embryos) are unable to undergo transformation when exposed to cellular or viral oncogenes. This review article will focus on the underlying molecular mechanisms that are responsible for the normal, physiological control of IGF-IR gene expression, as well as the cellular pathways that underlie its aberrant expression in cancer. Examples from the clinics will be presented, including a description of how the IGF system is involved in breast, prostate, pediatric, and gynecological cancers. Finally, current attempts to target the IGF-IR as a therapeutic approach will be described.
Similar articles
- The insulin-like growth factor-I receptor gene: a downstream target for oncogene and tumor suppressor action.
Werner H, Maor S. Werner H, et al. Trends Endocrinol Metab. 2006 Aug;17(6):236-42. doi: 10.1016/j.tem.2006.06.007. Epub 2006 Jul 11. Trends Endocrinol Metab. 2006. PMID: 16815029 - beta1A integrin expression is required for type 1 insulin-like growth factor receptor mitogenic and transforming activities and localization to focal contacts.
Goel HL, Breen M, Zhang J, Das I, Aznavoorian-Cheshire S, Greenberg NM, Elgavish A, Languino LR. Goel HL, et al. Cancer Res. 2005 Aug 1;65(15):6692-700. doi: 10.1158/0008-5472.CAN-04-4315. Cancer Res. 2005. PMID: 16061650 - Growth factor receptors as therapeutic targets: strategies to inhibit the insulin-like growth factor I receptor.
Surmacz E. Surmacz E. Oncogene. 2003 Sep 29;22(42):6589-97. doi: 10.1038/sj.onc.1206772. Oncogene. 2003. PMID: 14528284 Review. - Transcriptional regulation of the insulin-like growth factor-I receptor gene in breast cancer.
Sarfstein R, Maor S, Reizner N, Abramovitch S, Werner H. Sarfstein R, et al. Mol Cell Endocrinol. 2006 Jun 27;252(1-2):241-6. doi: 10.1016/j.mce.2006.03.018. Epub 2006 Apr 27. Mol Cell Endocrinol. 2006. PMID: 16647191 Review. - Caveolin-1 up-regulates IGF-I receptor gene transcription in breast cancer cells via Sp1- and p53-dependent pathways.
Glait C, Tencer L, Ravid D, Sarfstein R, Liscovitch M, Werner H. Glait C, et al. Exp Cell Res. 2006 Nov 15;312(19):3899-908. doi: 10.1016/j.yexcr.2006.08.016. Epub 2006 Aug 26. Exp Cell Res. 2006. PMID: 17014845
Cited by
- Metformin downregulates the insulin/IGF-I signaling pathway and inhibits different uterine serous carcinoma (USC) cells proliferation and migration in p53-dependent or -independent manners.
Sarfstein R, Friedman Y, Attias-Geva Z, Fishman A, Bruchim I, Werner H. Sarfstein R, et al. PLoS One. 2013 Apr 19;8(4):e61537. doi: 10.1371/journal.pone.0061537. Print 2013. PLoS One. 2013. PMID: 23620761 Free PMC article. - Targeting 3-phosphoinoside-dependent kinase-1 to inhibit insulin-like growth factor-I induced AKT and p70 S6 kinase activation in breast cancer cells.
Baxi SM, Tan W, Murphy ST, Smeal T, Yin MJ. Baxi SM, et al. PLoS One. 2012;7(10):e48402. doi: 10.1371/journal.pone.0048402. Epub 2012 Oct 31. PLoS One. 2012. PMID: 23119004 Free PMC article. Retracted. - Targeting non-small cell lung cancer cells by dual inhibition of the insulin receptor and the insulin-like growth factor-1 receptor.
Vincent EE, Elder DJ, Curwen J, Kilgour E, Hers I, Tavaré JM. Vincent EE, et al. PLoS One. 2013 Jun 24;8(6):e66963. doi: 10.1371/journal.pone.0066963. Print 2013. PLoS One. 2013. PMID: 23826179 Free PMC article. - Interaction between cyclooxygenase-2 and insulin-like growth factor in breast cancer: A new field for prevention and treatment.
Taromaru GC, DE Oliveira VM, Silva MA, Montor WR, Bagnoli F, Rinaldi JF, Aoki T. Taromaru GC, et al. Oncol Lett. 2012 Mar;3(3):682-688. doi: 10.3892/ol.2011.532. Epub 2011 Dec 21. Oncol Lett. 2012. PMID: 22740976 Free PMC article. - Molecular Signatures of the Insulin-like Growth Factor 1-mediated Epithelial-Mesenchymal Transition in Breast, Lung and Gastric Cancers.
Cevenini A, Orrù S, Mancini A, Alfieri A, Buono P, Imperlini E. Cevenini A, et al. Int J Mol Sci. 2018 Aug 15;19(8):2411. doi: 10.3390/ijms19082411. Int J Mol Sci. 2018. PMID: 30111747 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources